Initial concerns about SGLT2 inhibitors focussed on possible detrimental effects on the renal system, particularly to increase genito-urinary infections, compromise bladder health and aggravate acute kidney injury [3]. This evidence concerns the gene SLC5A2 and acute kidney injury.